本文選題：子宮內(nèi)膜癌 + 盆腔淋巴結(jié)轉(zhuǎn)移�。� 參考：《實用婦產(chǎn)科雜志》2015年04期

【摘要】：目的:探討子宮內(nèi)膜癌的手術(shù)方式及影響預后的危險因素。方法:回顧性分析資料完整、初治為手術(shù)治療并經(jīng)病理學診斷確診,且進行系統(tǒng)分期手術(shù)的358例子宮內(nèi)膜癌患者的臨床情況及手術(shù)方式,并進行隨訪。對可能影響子宮內(nèi)膜癌患者預后的危險因素進行分析。結(jié)果:358例患者中位發(fā)病年齡52歲(20~78歲),3年總體無瘤生存率分別為Ⅰ期97.12%,Ⅱ期91.67%;Ⅲ期85.19%,復發(fā)及死亡14例。開腹手術(shù)326例(91.06%),腹腔鏡手術(shù)32例(8.94%)。與開腹組手術(shù)患者比較,腹腔鏡組手術(shù)時間較長、平均估計術(shù)中失血量較少且平均住院時間短,差異有統(tǒng)計學意義(P0.05)。單因素分析表明,有內(nèi)科合并癥、手術(shù)病理分期晚、僅行盆腔淋巴結(jié)取樣、脈管癌栓陽性、盆腔和(或)腹主動脈旁淋巴結(jié)轉(zhuǎn)移是影響子宮內(nèi)膜癌患者預后的危險因素;多因素分析表明,盆腔淋巴結(jié)轉(zhuǎn)移是影響子宮內(nèi)膜癌患者預后的獨立危險因素(P=0.000,OR=11.901,95%CI3.291~43.039)。結(jié)論:子宮內(nèi)膜癌以開腹手術(shù)為主,腹腔鏡手術(shù)顯示了微創(chuàng)的優(yōu)勢。手術(shù)病理分期晚期、伴有內(nèi)科合并癥、僅行盆腔淋巴結(jié)取樣術(shù)、脈管癌栓陽性、腹主動脈旁淋巴結(jié)轉(zhuǎn)移,特別是有盆腔淋巴結(jié)轉(zhuǎn)移的子宮內(nèi)膜癌患者預后差。
[Abstract]:Objective: to investigate the surgical methods and prognostic factors of endometrial carcinoma. Methods: a total of 358 patients with endometrial carcinoma who were treated by surgery and diagnosed by pathology were retrospectively analyzed and followed up. To analyze the risk factors that may affect the prognosis of endometrial carcinoma patients. Results the median age of disease was 52 years old or 2078 years old. The overall survival rate of 3 years was 97.12 for stage 鈪，

本文編號：1807247